Abstract: A titanium alloy according to the present invention contains oxygen at a content increased more than a conventional alloy. The titanium alloy includes, relative to 100 atomic % (at %) of the entire amount of the titanium alloy, 15 to 27 at % of tantalum (Ta), 1 to 8 at % of tin (Sn), 0.4 to 1.7 at % of oxygen (O), and a balance of titanium (Ti) and inevitable impurities. In the titanium alloy according to the present invention, an average particle diameter of an equiaxed ? phase desirably falls within a range of 0.01 ?m to 1.0 ?m. In the titanium alloy according to the present invention, an area ratio at which the equiaxed ? phase occupies per unit area desirably falls within a range of 0.1% to 10%.

Abstract: A hub assembly comprises a hub axle, a hub body, a sprocket support body, a one-way clutch, and a transmitting body. The hub body is rotatable relative to the hub axle about a rotational axis. The sprocket support body is rotatable relative to the hub axle the rotational axis. The transmitting body is provided between the sprocket support body and the one-way clutch to transmit rotational force from the sprocket support body to the one-way clutch. The transmitting body is a separate member from the sprocket support body. The transmitting body includes an outer periphery configured to be engaged with the inner periphery of the sprocket support body.

Abstract: The present disclosure provides novel pharmaceutical compositions, e.g., a pharmaceutical composition capable of improving the intestinal bacterial flora in vivo or increasing a short-chain fatty acid in vivo, which comprises MXene. Methods of treatment using such compositions are also provided.

Abstract: A machine tool includes: a bed; first and second movable bodies supported so as to be movable with respect to the bed; and first to fourth jacks configured to support the bed. A moving range of a gravity center of the first movable body is confined within a first triangle in which three of the first to fourth jacks are at vertices thereof when the machine tool is viewed from the top. A moving range of a gravity center of the second movable body is confined within a second triangle in which three of the first to fourth jacks are at vertices thereof when the machine tool is viewed from the top. A combination of the three jacks forming the first triangle and a combination of the three jacks forming the second triangle differ from each other.

Abstract: The disclosure provides pharmaceutical compositions comprising one or more nanofibers and/or nanoflakes of a material represented by the formula: MQaOb, wherein “M” is at least one element selected from the group consisting of Groups 3, 4, 5, 6, or 7; “Q” is at least one element selected from the group consisting of Groups 12, 13, 14, 15, or 16, provided that oxygen is excluded’; “a” is 0 or more and 2 or less; and “b” is greater than 0 and 2 or less. In some aspects, methods of treatment and prophylactic methods, based on the same, are also provided.

Abstract: [Problem] To prevent or suppress generation of polymers in the internal space of a protrusion unit. [Solution] A handling device 100 includes a flow unit 10, a protrusion unit 30, a spray unit 40, and a grid 50. The spray unit is configured to be able to be disposed in an internal space 31 of the protrusion unit and be able to spray liquid onto the inner wall surface of the protrusion unit with the spray unit disposed in the internal space. The grid is disposed at the boundary of a flow path 11 of the flow unit and the internal space of the protrusion unit to prevent irregular packing F packed in a packed bed 17 from moving to the internal space.

Abstract: A production method of a foil includes a foil forming step of processing a titanium alloy material made of a titanium alloy containing tantalum to form a foil and a foil treatment step of treating the foil. The foil treatment step includes a recrystallization heating step of heating the foil under vacuum or under an inert gas atmosphere to recrystallize a structure of the foil, and a foil treatment cooling step of, after the recrystallization heating step, cooling the foil at a cooling rate that is higher than or equal to a cooling rate in which a temperature of the foil decreases by ?150° C. per 10 minutes within a range until the temperature of the foil reaches 600° C. under vacuum or under an inert gas atmosphere to suppress growth of crystal grains in the structure of the foil, the growth being associated with the recrystallization.

Abstract: The present disclosure provides novel pharmaceutical compositions, e.g., a pharmaceutical composition capable of improving the intestinal bacterial flora in vivo or increasing a short-chain fatty acid in vivo, which comprises MXene. Methods of treatment using such compositions are also provided.

Abstract: A medical marker is provided that will remain at a predetermined site in a patient's body. The medical marker includes a helical body obtained by making a linear body in a helical shape. When the helical body is viewed from an axial direction of the helical body, a winding shape of a unit winding constituting one winding of the helical body is a non-perfect circle, and a plurality of the unit windings contiguously aligned in the axial direction overlap at a terminal end part of one of the adjacent unit windings and a start end part of the other of the adjacent unit windings. As a result, there is a phase difference in the winding shape by an amount of overlap.

Abstract: A furnace state estimation device (1) including: an input unit (11) configured to receive track record information and conditions of refining treatment; a model determination unit (14) configured to determine model parameters using past model parameters; a furnace state calculation unit (15) configured to calculate state quantities, including temperature and component concentration of molten metal and component concentration of slag, in a furnace, using the determined model parameters; and a model parameter calculation unit (13) configured to calculate model parameters in the refining treatment of the target charge, based on an evaluation function that includes terms representing a mass balance error and a heat balance error in the furnace from beginning to end of a particular period of time in the refining treatment, using track record information including results of the refining treatment of the target charge.

Abstract: There is provided a cuboid silver powder including silver particles having a BET specific surface area of 0.5 m2/g or less. An average aspect ratio of the cuboid silver powder is 1.2 or greater and less than 2.0 as determined by observing cross-sections of 100 or more silver particles from the silver particles. An average of a ratio represented by (Formula 1) below is 0.84 or greater. The ratio is a ratio of perimeter of one silver particle among the silver particles to perimeter of a rectangle circumscribing the one silver particle. L/(2×major axis+2×minor axis) ??(Formula 1): where L is the perimeter (?m) of the one silver particle, and the major axis and minor axis are respectively a long side (?m) and short side (?m) of the rectangle of minimum area circumscribing an outline of cross-section of the one silver particle.

Abstract: Provided is a method, comprising contacting a composition that comprises metal oxide nanofilaments to a dye and/or an organic compound under such conditions that the dye and/or the organic compound undergoes at least partial decomposition or degradation, the metal oxide nanofilaments the metal oxide nanofilaments optionally comprising titanium, the metal oxide nanofilaments optionally comprising carbon, the structure of the oxide nanofilaments optionally being an lepidocrocite structure; and further optionally comprising illuminating the composition and the dye and/or the organic compound. Also provided is a system, the system comprising a conduit and an amount of a composition that comprises a metal oxide nanofilaments, the conduit placing the composition into fluid communication with a process stream, the process stream comprising a dye and/or an organic compound.

Abstract: A pharmaceutical composition for adsorbing a disease-causing substance by oral administration, the pharmaceutical composition including two-dimensional particles having one or plural layers, the one or plural layers having a layer body represented by: MmXn, wherein M is at least one metal of Group 3, 4, 5, 6, or 7, X is a carbon atom, a nitrogen atom, or a combination thereof, n is not less than 1 and not more than 4, m is more than n but not more than 5, and a modifier or terminal T exists on a surface of the layer body, wherein Tis at least one selected from a hydroxyl group, a fluorine atom, a chlorine atom, an oxygen atom, and a hydrogen atom.

Abstract: An adsorbent material used for adsorbing a disease-causing substance, the adsorbent material including two-dimensional particles having one or plural layers, the one or plural layers containing a layer body represented by: MmXn, wherein M is at least one metal of Group 3, 4, 5, 6, or 7, X is a carbon atom, a nitrogen atom, or a combination thereof, n is not less than 1 and not more than 4, m is more than n but not more than 5, and a modifier or terminal T exists on a surface of the layer body, wherein T is at least one selected from a hydroxyl group, a fluorine atom, a chlorine atom, an oxygen atom, and a hydrogen atom.

Abstract: A controller of a press device causes a presser to stop pressing upon a press die being displaced by a specific dimension after a time point when a detection value provided by a pressing force detector has exceeded a threshold value.

Abstract: An adsorbent that includes: particles of a layered material including one or plural layers; and one or more metal atoms selected from Al, Mg, Ca, Ba, Fe, Zn, Mn, or Cu. The one or plural layers include a layer body represented by: MmXn wherein M is at least one metal of Group 3, 4, 5, 6, or 7, X is a carbon atom, a nitrogen atom, or a combination thereof, n is 1 to 4, and m is more than n and 5 or less. A modifier or terminal T exists on a surface of the layer body, T is at least one of a hydroxyl group, a fluorine atom, a chlorine atom, an oxygen atom, or a hydrogen atom, and the M of the layer body is bonded to at least one of a chlorine atom, a phosphorus atom, an iodine atom, or a sulfur atom.

Abstract: An adsorbent that includes a particle of a layered material that contains one or a plurality of layers; and contains Li. The one or plural layers includes a layer body represented by: MmXn where, M represents at least one Group-3, -4, -5, -6, or -7 metal, X represents a carbon atom, a nitrogen atom, or a combination thereof, n is 1 to 4, and m is larger than n, and equal to or less than 5; and a modified/terminal part T resides on a surface of the layer body, T represents at least one selected from the group consisting of hydroxy group, fluorine atom, chlorine atom, oxygen atom, and hydrogen atom, the modified/terminal part T residing on a surface of the layer body, the particle has an average thickness of 1 nm to 10 nm, and the adsorbent has a Li content of 0.0001% by mass to 0.0020% by mass.

Abstract: [Problem] Provided are a production method for a multi-input/multi-output-type genetic switch or a transcription factor, and a multi-input/multi-output-type genetic switch or a transcription factor. [Solving Means] The inventors of the present invention have completed a production method for a multi-input/multi-output-type genetic switch or a transcription factor, essentially including the steps of “fusing two or more transcription factor genes to each other” and “introducing mutations into the fusion-type transcription factor gene,” and have further succeeded in obtaining a multi-input/multi-output-type genetic switch or a transcription factor by the method.

Abstract: A raw blank for vacuum carburization is provided. The raw blank for vacuum carburization has a chemical composition containing, by mass, C: 0.13 to 0.28%, Si: 0.01 to 1.20%, Mn: 0.10 to 1.50%, P: 0.030% or less, S: 0.050% or less, Cr: 0.30 to 2.20%, Al: 0.027 to 0.090%, N: 0.0060 to less than 0.0140%, and, as an optional element, Mo: 0.60% or less, the remainder being Fe and unavoidable impurities, and satisfying the following formula (1). AlN precipitates having an equivalent circle diameter of 100 nm or more exist at 1.5 pieces/100 ?m2 or less in a cross section of the raw blank. Al×N?0.00090??(1) It is noted that element symbols in the formula (1) denote a value of content (% by mass) of each element.

Abstract: A medical marker is provided that will remain at a predetermined site in a patient's body. The medical marker includes a helical body obtained by making a linear body in a helical shape. When the helical body is viewed from an axial direction of the helical body, a winding shape of a unit winding constituting one winding of the helical body is a non-perfect circle, and a plurality of the unit windings contiguously aligned in the axial direction overlap at a terminal end part of one of the adjacent unit windings and a start end part of the other of the adjacent unit windings. As a result, there is a phase difference in the winding shape by an amount of overlap.